Assembly Speaker Pro Tem Steve Yeager (D) announced several new members of the Democratic Caucus leadership team for the 2023 biennial legislative session. They are Assemblywoman Sandra Jauregui, Majority Floor Leader, and Assemblywoman Daniele Monroe-Moreno, Chair of Assembly Ways & Means Committee.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Walgreens pharmacist Amy Bachyrycz and Dale Tinker, Executive Director of the New Mexico Pharmacists Association, were honored last week by the New Mexico Immunization Coalition, receiving the “Immunization Champion” award.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The New York State Workers Compensation Board published a final rule requiring that providers be notified when a provider network exists.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The Board of Pharmacy is considering adopting proposed rules on temperature at its upcoming February Board meeting.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Board of Pharmacy posted the agenda and meeting materials for its meeting being held December 14-16.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Please see the December 2022 provider update found here on the Executive Officer of Health and Human Services (EOHHS) website.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Gov. Bill Lee (R) named Dr. Ralph Alvardo, MD, FACP as the Commissioner for Tennessee Department of Health. Dr. Alvardo brings decades of diverse professional experience to Tennessee, which includes nearly 30 years as an attending physician, serving in the Kentucky State Senate since 2015 and leading the Senate Health and Welfare Committee as chairman since 2019.
Also in Tennessee, TennCare announces additional drugs to the CoverRx list, including Synthroid, Armour Thyroid and Nicotine Replacement Therapy (NRT). The TennCare CoverRx coverage was effective December 1.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
NACDS provided comments to the Health and Human Services Commission’s Vendor Drug on proposed policies related to the transition of the Medicaid pharmacy formulary, preferred drug list and prior authorization requirements to managed care organizations.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
NACDS provided comments in advance of the Washington State House Health Care and Wellness Committee’s December 1 workshop meeting on “Pharmacy Benefit Manager Impacts on Prescription Drug Cost and Regulatory Developments.” In our letter, NACDS urged legislative action to curb harmful pharmacy benefit manager (PBM) practices including patient-steering, limiting pharmacies’ participation in provider networks and reimbursement practices that result in below-cost reimbursement to pharmacy providers.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
